Sinew Pharma Inc. (TPEX:6634)
Taiwan · Delayed Price · Currency is TWD 60.00
0.00 (0.00%)
Aug 19, 2026, 9:52 AM CST
Sinew Pharma Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -118.43 | -123.75 | -150.37 | -170.92 | -140.18 | -91.58 |
Depreciation & Amortization | 11.52 | 19.25 | 30.21 | 28.95 | 22.78 | 22.59 |
Other Amortization | 0.09 | 0.09 | 0.1 | 0.03 | 0.03 | 0.06 |
Stock-Based Compensation | 10.63 | 17.01 | 20.16 | 18 | 16.71 | 12.1 |
Other Operating Activities | -1.34 | -1.91 | -1.45 | -0.86 | -0.45 | -0.41 |
Change in Accounts Receivable | - | -0.05 | - | 0.23 | -0.34 | 0.15 |
Change in Accounts Payable | 0.49 | -4.8 | -3.72 | 8.68 | 5.54 | - |
Change in Unearned Revenue | - | - | - | - | -0.33 | 0.85 |
Change in Other Net Operating Assets | -0.62 | -1.13 | -1 | -2.16 | 2.47 | -1.06 |
Operating Cash Flow | -97.67 | -95.3 | -106.08 | -118.05 | -93.76 | -57.32 |
Operating Cash Flow Growth | - | - | - | - | - | - |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Capital Expenditures | -0.66 | -0.63 | -0.18 | -7.21 | -5.23 | -2.18 |
Sale (Purchase) of Intangibles | -1.45 | -1.24 | -1.15 | -0.24 | -0.66 | -3.69 |
Investment in Securities | 109 | 90.8 | -9 | 35.8 | -213 | -640 |
Other Investing Activities | -2.53 | -4.18 | -6.36 | -2.15 | -2.26 | -2.7 |
Investing Cash Flow | 104.36 | 84.75 | -16.69 | 26.2 | -221.15 | -648.56 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Long-Term Debt Repaid | - | -6.22 | -6.46 | -6.1 | -2.76 | -2.29 |
Net Debt Issued (Repaid) | -5.76 | -6.22 | -6.46 | -6.1 | -2.76 | -2.29 |
Issuance of Common Stock | - | 0.65 | 3.82 | 18.08 | 13.17 | 1,213 |
Financing Cash Flow | -5.76 | -5.58 | -2.65 | 11.98 | 10.41 | 1,210 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Cash Flow | 0.93 | -16.12 | -125.42 | -79.87 | -304.49 | 504.35 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -98.33 | -95.93 | -106.26 | -125.26 | -98.99 | -59.5 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Margin | -209212.77% | -204112.77% | - | - | -30178.66% | -955.19% |
Free Cash Flow Per Share | -1.38 | -1.35 | -1.49 | -1.78 | -1.43 | -1.00 |
Levered Free Cash Flow | -58.84 | -61.42 | -63.29 | -71.93 | -51.5 | -34.31 |
Unlevered Free Cash Flow | -58.14 | -61 | -63.03 | -71.44 | -51.33 | -34.22 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash Interest Paid | 0.66 | 0.66 | 0.41 | 0.78 | 0.28 | 0.15 |
Cash Income Tax Paid | 0.78 | 0.78 | 0.46 | - | - | - |
Change in Working Capital | -0.13 | -5.98 | -4.73 | 6.75 | 7.35 | -0.07 |